Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

5.2K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
5.2K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

975
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
975
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

617
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
617

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of a diagnostic model for malignant pleural effusion based on random forest.

Journal of thoracic disease·2026
Same author

Pleural fluid C-C motif chemokine ligand 2 as a diagnostic biomarker for malignant pleural effusion.

Journal of thoracic disease·2026
Same author

Immunorepertoire-based characterization of adaptive immunity in human malignant pleural effusion.

Frontiers in oncology·2026
Same author

Immunodynamic changes in a mouse model of malignant pleural effusion.

Laboratory animal research·2026
Same author

Dexamethasone-induced immunosuppression in Pneumocystis pneumonia reprograms neutrophil metabolism and impairs antimicrobial function.

Biochemical and biophysical research communications·2025
Same author

T-cell subsets in <i>Pneumocystis</i> pneumonia.

Clinical & translational immunology·2025

Related Experiment Video

Updated: Mar 16, 2026

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
03:22

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion

Published on: November 10, 2023

1.8K

Tuberculous pleural effusion.

Kan Zhai1, Yong Lu1, Huan-Zhong Shi1

  • 1Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.

Journal of Thoracic Disease
|August 9, 2016
PubMed
Summary
This summary is machine-generated.

Tuberculosis pleural effusion (TPE) is a common cause of illness globally. Diagnosing TPE in high-prevalence areas can be simplified by measuring adenosine deaminase levels in pleural fluid.

Keywords:
Pleural effusiontuberculosistuberculous pleurisy

More Related Videos

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

737
Point-of-Care Lung Ultrasound in Adults: Image Acquisition
09:17

Point-of-Care Lung Ultrasound in Adults: Image Acquisition

Published on: March 3, 2023

8.0K

Related Experiment Videos

Last Updated: Mar 16, 2026

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
03:22

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion

Published on: November 10, 2023

1.8K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

737
Point-of-Care Lung Ultrasound in Adults: Image Acquisition
09:17

Point-of-Care Lung Ultrasound in Adults: Image Acquisition

Published on: March 3, 2023

8.0K

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Microbiology

Background:

  • Tuberculosis (TB) is a leading cause of pleural effusions worldwide, particularly in developing nations.
  • Tuberculous pleural effusion (TPE) represents a significant extrapulmonary manifestation of TB.
  • TPE typically presents with acute symptoms including fever, cough, and pleuritic chest pain.

Purpose of the Study:

  • To review the diagnostic approaches and treatment strategies for tuberculous pleural effusion.
  • To highlight the utility of adenosine deaminase (ADA) levels in diagnosing TPE in endemic regions.

Main Methods:

  • Review of diagnostic criteria for TPE.
  • Discussion of microbiological and histological confirmation methods.
  • Evaluation of biochemical markers such as adenosine deaminase (ADA) and interferon-gamma (IFN-γ).

Main Results:

  • The pleural fluid in TPE is typically an exudate with a lymphocytic predominance.
  • Microscopy, culture, and histology for Mycobacterium tuberculosis remain the gold standard for diagnosis.
  • Adenosine deaminase levels above 40 U/L in pleural fluid are highly suggestive of TPE in high-prevalence areas.

Conclusions:

  • TPE is a curable condition requiring prompt diagnosis and treatment.
  • Biochemical markers like ADA offer a practical diagnostic tool for TPE, especially in resource-limited settings.
  • Standardized anti-TB drug regimens are effective for treating TPE.